

( (S (NP-SBJ (NP Ciba-Geigy Ltd.)
             and
             (NP Chiron Corp.))
     (VP said
         (SBAR 0
               (S (NP-SBJ they)
                  (VP extended
                      (NP (NP their offer)
			  (PP for
			      (NP Connaught BioSciences Inc.))
                          ,
                          (VP valued
                              (NP *)
                              (PP-CLR at
				      (NP (NP (QP 866 million) Canadian dollars)
					  (PRN -LRB-
					       (NP (QP US$ 736 million) *U*)
					       -RRB-)))))
                      (PP-DIR to 
			      (NP Oct. 27))))))
     .))
( (S (NP-SBJ The companies)
     (ADVP-TMP earlier)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 they)
                  (VP did n't
                      (VP want
                          (S (NP-SBJ-2 *-1)
                             (VP to
                                 (VP raise
                                     (NP their offer)
                                     (S-PRP (NP-SBJ *-2)
					    (VP to
						(VP match
						    (NP (NP a rival bid)
							(PP by
							    (NP Institut Merieux S.A.))
							(PP of
							    (NP (NP (NP C$ 37 *U*)
								    (NP-ADV a share))
								, 
								or
								(NP (QP C$ 942 million) *U*)))))))))))))))
     .))
( (S But
     (NP-SBJ they)
     (VP said
         (SBAR 0
               (S (NP-SBJ-3 (NP the (ADJP C$ 30-a-share *U*) bid)
			    ,
			    (SBAR (WHNP-1 which)
				  (S (NP-SBJ-2 *T*-1)
				     (VP was
					 (ADJP-PRD due
						   (S (NP-SBJ *-2)
						      (VP to
							  (VP expire
							      (NP-TMP Monday))))))))
			    ,)
                  (VP may
                      (ADVP-TMP still)
                      (VP be
                          (VP extended
                              or
                              varied
			      (NP *-3)))))))
     .))
( (S (NP-SBJ (NP Merieux)
             ,
             (NP (NP a vaccine manufacturer)
                 (VP based
                     (NP *)
                     (PP-LOC-CLR in
				 (NP (NP Lyon)
				     ,
				     (NP France)
				     ,)))))
     (VP is
         (ADJP-PRD 51%-held
                   (PP by
                       (NP French 
			   state-owned
                           Rhone-Poulenc S.A))))
     .))
( (S (NP-SBJ Ciba-Geigy)
     (VP is
         (NP-PRD (NP a major pharmaceutical concern)
		 (VP based
		     (NP *) 
		     (PP-LOC-CLR in
				 (NP (NP Basel)
				     ,
				     (NP Switzerland))))))
     .))
( (S (NP-SBJ-1 (NP Chiron)
               ,
               (NP another pharmaceutical concern)
               ,)
     (VP is
         (VP based
             (NP *-1)
             (PP-LOC-CLR in
			 (NP (NP Emeryville)
			     ,
			     (NP Calif)))))
     .))
( (S (NP-SBJ Connaught)
     (VP is
         (NP-PRD a biotechnology research and vaccine manufacturing concern))
     .))
( (S (NP-SBJ (NP (NP Institut Merieux 's)
		 bid)
             (PP for
                 (NP Toronto-based Connaught)))
     (VP has
         (VP run
             (PP-DIR into
		     (NP (NP problems)
			 (PP with
			     (NP (NP the Canadian government)
				 ,
				 (SBAR (WHNP-1 which)
				       (S (NP-SBJ *T*-1)
					  (VP told
					      (NP Merieux)
					      (NP-TMP last week)
					      (SBAR that
						    (S (NP-SBJ-2 it)
						       (VP was n't
							   (VP convinced
							       (NP *-2)
							       (SBAR that
								     (S (NP-SBJ the proposed acquisition)
									(VP would
									    (VP be
										(PP-PRD of
											(NP `` 
											    (NP net benefit)
											    ''
											    (PP to
												(NP Canada)))))))))))))))))))))
     .))
( (S (NP-SBJ-1 Merieux officials)
     (VP are
         (VP expected
             (S (NP-SBJ-2 *-1)
                (VP to
                    (VP meet
                        (PP-CLR with
				(NP federal officials))
                        (PP-LOC in
				(NP Ottawa))
			(NP-TMP today)
			(S-PRP (NP-SBJ *-2)
			       (VP to
				   (VP discuss
				       (NP the decision)))))))))
     .))
